Finance

Lists
OXB:LON
Oxford BioMedica plc
514,68 GBX
+0,13%
(+0,68) 1D
14 հոկ, 08:07:32 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OXB...
Open
510,00 GBX
High
515,00 GBX
Low
510,00 GBX
Mkt. cap
623,02 մլն
Avg. vol.
711,24 հզր
Volume
996,00
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 մլն
No. of employees
1 հզր
Open
510,00 GBX
High
515,00 GBX
Low
510,00 GBX
Mkt. cap
623,02 մլն
Avg. vol.
711,24 հզր
Volume
996,00
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOFrank Mathias
Employees1,02 հզր
Founded1995
Headquarters-
Sector-
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
47,76 մլն
47,76 մլն
39,92 մլն
39,92 մլն
Cost of goods sold
30,60 մլն
30,60 մլն
25,35 մլն
25,35 մլն
Cost of revenue
30,60 մլն
30,60 մլն
25,35 մլն
25,35 մլն
Research and development expenses
1,54 մլն
1,54 մլն
1,14 մլն
1,14 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 մլն
19,65 մլն
24,36 մլն
24,36 մլն
Operating expense
20,93 մլն
20,93 մլն
25,29 մլն
25,29 մլն
Total operating expenses
51,52 մլն
51,52 մլն
50,64 մլն
50,64 մլն
Operating income
-3,76 մլն
-3,76 մլն
-10,72 մլն
-10,72 մլն
Other non operating income
-323,00 հզր
-323,00 հզր
-141,50 հզր
-141,50 հզր
EBT including unusual items
-2,95 մլն
-2,95 մլն
-18,11 մլն
-18,11 մլն
EBT excluding unusual items
-7,26 մլն
-7,26 մլն
-14,29 մլն
-14,29 մլն
Income tax expense
-1,07 մլն
-1,07 մլն
372,00 հզր
372,00 հզր
Effective tax rate
36,20%
36,20%
-2,05%
-2,05%
Other operating expenses
-259,50 հզր
-259,50 հզր
-212,50 հզր
-212,50 հզր
Net income
-1,88 մլն
-1,88 մլն
-18,48 մլն
-18,48 մլն
Net profit margin
-3,94%
-3,94%
-46,29%
-46,29%
Earnings per share
-
-
-
-
Interest and investment income
649,50 հզր
649,50 հզր
917,00 հզր
917,00 հզր
Interest expense
-3,55 մլն
-3,55 մլն
-3,94 մլն
-3,94 մլն
Net interest expenses
-2,90 մլն
-2,90 մլն
-3,02 մլն
-3,02 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,06 մլն
-2,06 մլն
-7,43 մլն
-7,43 մլն
Gain or loss from assets sale
53,00 հզր
53,00 հզր
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps